In today’s whirlwind of diagnostics, vaccines and therapeutics, we take a step back and look at how the world of development and manufacturing of biologics has evolved over the last 25 years, bringing together EuropaBio Members and 25th Anniversary Sponsor, Catalent.
We look back at changing experience from the last quarter of a century in the pathway to patients, plus how the latest advanced technologies translate into effective pre-clinical and clinical development and manufacturing. Hear expert presentations from EuropaBio Members and Catalent Biologics, before a detailed Q&A session with the audience on all aspects of developing a successful biologic in 2021.
Aspects to be discussed include:
Behzad Mahdavi, Ph.D.
Vice President of Open Innovation, Biologics, Cell and Gene Therapy
Scientific Director, Janssen R&D/Clinical Innovation
With over 20 years’ experience in developing and implementing impactful growth strategies in the biopharmaceutical industries, Dr. Mahdavi joined Catalent in 2020 after a 13-year career at Lonza, where he held the role of Vice President Strategic Innovation & Alliances, and various board-level positions at other innovative companies. Prior to joining Lonza, he was Chief Executive Officer of SAM Electron Technologies, a venture capital-backed company in the life sciences field. He holds a doctorate in chemistry from the University of Sherbrooke, Canada, and also has a master’s in business administration from the University of Quebec in Montreal.
Join this webinar co-organised by Catalent and EuropaBio in the framework of EuropaBio 25th Anniversary and take part to the celebrations!
+32 2 735 03 13